MedTrace Logo

Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia

NCT00004399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2015-03-25

No results posted yet for this study

Summary

OBJECTIVES:

I. Determine the effectiveness of nimodipine versus magnesium sulfate in the prevention of eclamptic seizures in patients with severe preeclampsia.

Conditions

  • Pre-eclampsia

Interventions

DRUG

magnesium sulfate

DRUG

nimodipine

Sponsors & Collaborators

  • University of Utah

    collaborator OTHER

  • FDA Office of Orphan Products Development

    lead FED

Principal Investigators

  • Michael Anthony Belfort · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-09-30
Completion
2000-08-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004399 on ClinicalTrials.gov